Delivery Order SPE2DB20D9214-SPE2DB25FD4XN
Award Date 9/3/25
Potential Completion Date 9/24/25
Potential Value $36K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $18,149.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The award represents a discrete purchase order issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,132.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries an ultimate completion date of September 30, 2025, and was awarded on September 9, 2025, with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its Park Ridge facility, delivering...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $15,860.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, valued at $18,238.39, was awarded on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,238.39 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prolastin C 1,000 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain. The award...
- The Defense Logistics Agency (DLA) awarded a $18,132.25 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will occur at the vendor's facility in Park Ridge, Illinois. This delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $27,403.64 for Prolastin C 1,000 mg/20 ml vials. The award, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain operations, which serves as the government's primary source for...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $27,403.64 to DMS Pharmaceutical Group Inc. for the supply of Prolastin C 1,000 mg/20 ml vials. The contract, which carries no set-aside designation, is scheduled for completion by September 23, 2025, and will be fulfilled from the vendor's distribution facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will deliver this...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,273.77 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $35,824.80 to DMS Pharmaceutical Group Inc. on June 16, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's broader contract vehicle with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted...